Patient-Centered Communication for Discussing Oncotype DX Testing

Cancer Invest. 2016 May 27;34(5):205-12. doi: 10.3109/07357907.2016.1172637. Epub 2016 Apr 28.

Abstract

Oncotype DX testing (ODX), a tumor gene expression test, may improve breast cancer care, however, communicating results remains challenging. We identified patient-centered communication strategies/gaps for discussing ODX results. We applied a patient-centered communication framework to analyze qualitative interviews with oncologists about how they communicate about ODX with patients, using template analysis in Atlas.ti. Overall, providers discussed four patient-centered communication domains: exchanging information, assessing uncertainty, making decisions and cross-cutting themes. Providers did not report discussing emotional aspects of managing uncertainty, assessing decision-making preferences, and evaluating decisions. A patient-centered approach may be a model for communicating about tumor gene expression tests.

Keywords: Breast cancer; Communication; Patient-centered communication; Qualitative methods; Tumor gene profiling.

MeSH terms

  • Biomarkers, Tumor*
  • Breast Neoplasms / diagnosis*
  • Breast Neoplasms / epidemiology
  • Breast Neoplasms / genetics*
  • Breast Neoplasms / therapy
  • Clinical Decision-Making
  • Female
  • Gene Expression Profiling / methods
  • Genetic Testing* / methods
  • Health Care Surveys
  • Health Communication*
  • Humans
  • Male
  • North Carolina
  • Oncologists
  • Patient-Centered Care* / methods
  • Precision Medicine / methods
  • Sensitivity and Specificity
  • Uncertainty

Substances

  • Biomarkers, Tumor